The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes

Mesenchymal stromal cell (MSC) therapy is a promising tool in the treatment of chronic inflammatory diseases. This has been ascribed to the capacity of MSC to release a large variety of immune-modulatory factors. However, all aspects of the mode of therapeutic MSC action in different diseases remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavin, Caroline, Meinke, Stephan, Heldring, Nina, Heck, Kathleen Anne, Achour, Adnane, Iacobaeus, Ellen, Höglund, Petter, Le Blanc, Katarina, Kadri, Nadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763726/
https://www.ncbi.nlm.nih.gov/pubmed/31616424
http://dx.doi.org/10.3389/fimmu.2019.02249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763726/
https://www.ncbi.nlm.nih.gov/pubmed/31616424
http://dx.doi.org/10.3389/fimmu.2019.02249

Ejemplares similares